| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $114.4M | -3.4% |
| Cost of Revenue | $85.2M | -1.3% |
| R&D Expense | $4.5M | -4.4% |
| SG&A Expense | $22.7M | +2.1% |
| Operating Income | -$18.1M | -286.8% |
| Pre-tax Income | -$20.6M | -55.8% |
| Income Tax | -$185K | -256.8% |
| Net Income | -$18.7M | -56.4% |
| EPS (Basic) | -$0.20 |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.1M | -41.0% |
| Accounts Receivable | $8.3M | -37.2% |
| Inventory | $1.6M | -11.9% |
| Current Assets | $15.2M | -37.3% |
| Total Assets | $40.5M | -36.6% |
| Current Liabilities | $36.4M | -22.3% |
| Total Liabilities | $48.9M | -14.6% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $6.4M | -7.0% |
| Capital Expenditures | $3.1M | +0.6% |
| Investing Cash Flow | -$3.1M | +22.8% |
| Financing Cash Flow | -$6.2M | -44.8% |
| Free Cash Flow | $3.3M | -13.0% |
| -42.9% |
| Stockholders' Equity |
| -$17.8M |
| -103.3% |